Belgium· BE-AMP-SAM663610-00

Fluad

A influenza, inaktiviert, spalt/split virus oder oberflächen-antigen product containing influenza virus surface antigen (haemagglutinin and neuraminidase), inactivated, registered in Belgium by Seqirus Netherlands. The same ATC class is registered in 11 of our 19 countries.

ATC J07BB02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedFluadATCJ07BB02REGISTER NO.BE-AMP-SAM663610-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BB02 (influenza, inaktiviert, spalt/split virus oder oberflächen-antigen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Influenza, inaktiviert, spalt/split virus oder oberflächen-antigen · ATC J07BB02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Influenza Virus Surface Antigen (Haemagglutinin and Neuraminidase), Inactivated
Manufacturer
Seqirus Netherlands
Country
Belgium (BE)
ATC code
J07BB02
ATC class
Influenza, inaktiviert, Spalt/Split Virus oder Oberflächen-Antigen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

2 priced
  • be_apb
    4889218
    EUR 30.87
  • be_apb
    7746142
  • be_apb
    5805445
    EUR 30.87

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fab38677-d741-46a5-9d93-7697fdea17b7
GET /v1/drugs/fab38677-d741-46a5-9d93-7697fdea17b7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection in pre-filled syringe",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Fluad",
  "name_fr": "Fluad",
  "name_nl": "Fluad",
  "amp_code": "SAM663610-00",
  "strengths": [
    "1.1750",
    "1.1750"
  ],
  "pack_count": 8,
  "substances": [
    "Influenza Virus Surface Antigen (Haemagglutinin and Neuraminidase), Inactivated",
    "Disodium Hydrogen Phosphate Dihydrate",
    "Potassium Chloride",
    "Potassium Dihydrogen Phosphate",
    "Sodium Chloride",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Influenza, Inactivated, Split Virus Or Surface Antigen",
  "authorisation_numbers": [
    "EU/1/24/1878/001",
    "EU/1/24/1878/002",
    "EU/1/24/1878/004",
    "EU/1/24/1878/003"
  ]
}

See everything about influenza, inaktiviert, spalt/split virus oder oberflächen-antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.